5-(4-acetamidophenyl)pyrazin-2(1h)-one has been researched along with carbachol in 2 studies
Studies (5-(4-acetamidophenyl)pyrazin-2(1h)-one) | Trials (5-(4-acetamidophenyl)pyrazin-2(1h)-one) | Recent Studies (post-2010) (5-(4-acetamidophenyl)pyrazin-2(1h)-one) | Studies (carbachol) | Trials (carbachol) | Recent Studies (post-2010) (carbachol) |
---|---|---|---|---|---|
38 | 0 | 0 | 13,918 | 81 | 968 |
Protein | Taxonomy | 5-(4-acetamidophenyl)pyrazin-2(1h)-one (IC50) | carbachol (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.7849 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 2.0626 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 3.4134 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 2.9961 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 2.535 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 2.9961 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 2.6638 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.849 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 4.99 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beleta, J; Berga, P; Bou, J; Cardelús, I; Fernández, AG; Gristwood, RW; Llenas, J | 1 |
English, TA; Gristwood, RW; Owen, DA; Sampford, KA; Wallwork, J | 1 |
2 other study(ies) available for 5-(4-acetamidophenyl)pyrazin-2(1h)-one and carbachol
Article | Year |
---|---|
Studies on the cardiac actions of flosequinan in vitro.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Action Potentials; Animals; Carbachol; Guinea Pigs; Heart; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Pyrazines; Pyrrolidinones; Quinolines; Rolipram; Vasodilator Agents | 1992 |
Analysis of responses to a selective phosphodiesterase III inhibitor, SK&F 94120, on isolated myocardium, including human ventricular myocardium from "end-stage" failure patients.
Topics: Animals; Carbachol; Cats; Female; Guinea Pigs; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyrazines; Swine | 1987 |